Literature DB >> 10448094

The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting migration and enhancing cell loss of vascular smooth muscle cells.

N Negoro1, M Hoshiga, M Seto, E Kohbayashi, M Ii, R Fukui, N Shibata, T Nakakoji, F Nishiguchi, Y Sasaki, T Ishihara, N Ohsawa.   

Abstract

Smooth muscle cell (SMC) migration plays an important role in restenosis after angioplasty. Myosin phosphorylation is necessary for cell migration. Fasudil is an inhibitor of protein kinases, including myosin light chain kinase and Rho associated kinase, thereby inhibiting myosin phosphorylation, and it has been clinically used to prevent vasospasm following subarachnoid hemorrage. Based on these findings, we examined the anti-migrative action of fasudil. In SMC (SM-3), fasudil (1-100 microM) inhibited SMC migration in a dose-dependent manner (p < 0.001). Fasudil suppressed actin stress fiber formation dose dependently. In rabbit carotid artery, fasudil (10 mg/kg/day) markedly reduced intimal hyperplasia 14 days following balloon injury. Cell kinetic study showed that fasudil did not affect proliferation but enhanced cell loss in the media after injury. We concluded that fasudil reduced neointimal formation after balloon injury through both inhibiting migration and enhancing cell loss of medial SMC. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448094     DOI: 10.1006/bbrc.1999.1129

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury.

Authors:  Neeta Adhikari; Nathan Charles; Ute Lehmann; Jennifer L Hall
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

2.  Antianginal effects of hydroxyfasudil, a Rho-kinase inhibitor, in a canine model of effort angina.

Authors:  T Utsunomiya; S Satoh; I Ikegaki; Y Toshima; T Asano; H Shimokawa
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  Adrenal androgen dehydroepiandrosterone sulfate inhibits vascular remodeling following arterial injury.

Authors:  Masaaki Ii; Masaaki Hoshiga; Nobuyuki Negoro; Ryosuke Fukui; Takahiro Nakakoji; Eiko Kohbayashi; Nobuhiko Shibata; Daisuke Furutama; Tadashi Ishihara; Toshiaki Hanafusa; Douglas W Losordo; Nakaaki Ohsawa
Journal:  Atherosclerosis       Date:  2009-02-27       Impact factor: 5.162

Review 4.  The pericyte: cellular regulator of microvascular blood flow.

Authors:  Matthew E Kutcher; Ira M Herman
Journal:  Microvasc Res       Date:  2009-02-07       Impact factor: 3.514

5.  Chronic allograft rejection: A significant hurdle to transplant success.

Authors:  Malgorzata Kloc; Rafik M Ghobrial
Journal:  Burns Trauma       Date:  2014-01-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.